Risk assessment of genetically modified food and neoliberalism: An argument for democratizing the regulatory review protocol of the Food and Drug Administration

Download Edit this record How to cite View on PhilPapers
Abstract
The primary responsibility of the US Food and Drug Administration is to protect public health by ensuring the safety of the food supply. To that end, it sometimes conducts risk assessments of novel food products, such as genetically modified food. The FDA describes its regulatory review of GM food as a purely scientific activity, untainted by any normative considerations. This paper provides evidence that the regulatory agency is not justified in making that claim. It is argued that the FDA’s policy stance on GM food is shaped by neoliberal considerations. The agency’s review of a genetically engineered animal, the AquAdvantage salmon, is used as a case study to track the influence of neoliberalism on its regulatory review protocol. After that, an epistemic argument justifying public engagement in the risk assessment of new GM food is outlined. It is because risk evaluations involve normative judgments, in a democracy, layperson representatives of informal epistemic communities that could be affected by a new GM food should have the opportunity to decide the ethical, political or other normative questions that arise during the regulatory review of that entity
ISBN(s)
PhilPapers/Archive ID
MEGRAO-2
Revision history
Archival date: 2019-10-06
View upload history
References found in this work BETA

View all 23 references / Add more references

Citations of this work BETA

Add more citations

Added to PP index
2014-07-30

Total views
139 ( #27,773 of 50,209 )

Recent downloads (6 months)
66 ( #8,294 of 50,209 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks to external links.